It only takes one drug to produce massive returns, as Seattle Genetics (NASDAQ:SGEN), Medivation (NASDAQ:MDVN), and Regeneron Pharmaceuticals (NASDAQ:REGN) have shown. Click on the slideshow below to learn more about their drugs, and find three more companies that are hoping to become one-drug wonders this year.